Back
Compare AU
Compare WVOL vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares MSCI World Ex Aust Minimum Volatility ETF (WVOL) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
WVOL | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 5 | 74 |
Median incremental investment | $3,169.00 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $6,478.04 | $2,020.48 |
Average age group | > 35 | > 35 |
Key Summary
WVOL | DRUG | |
|---|---|---|
Strategy | WVOL.AX was created on 2016-10-11 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 73.73m in AUM and 405 holdings. The fund aims to provide investors with the performance of the MSCI World Minimum Volatility (AUD) Index, before fees and expenses. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | EXXON MOBIL CORP (1.24 %) JOHNSON & JOHNSON (1.12 %) DUKE ENERGY CORP (1.01 %) | AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Information Technology (20.14 %) Health Care (13.50 %) Consumer Staples (10.71 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (66.15 %) Japan (10.60 %) Canada (4.16 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.3 % | 0.57 % |
Key Summary
WVOL | DRUG | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | MSCI World Minimum Volatility (AUD) Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.3 % | 0.57 % |
Price | $45.72 | $8.96 |
Size | $62.413 million | $173.171 million |
10Y return | N/A | 83.98 % |
Annual distribution yield (5Y) | 2.75 % | 1.82 % |
Market | ASX | ASX |
First listed date | 14/10/2016 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
WVOL | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 5 | 74 |
Median incremental investment | $3,169.00 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $6,478.04 | $2,020.48 |
Average age group | > 35 | > 35 |
Pros and Cons
WVOL | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
WVOL | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |